Experiment: 7QCC

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.8 mM [U-15N] WBSCR27, 10 mM DTT, 0.2 % w/v sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride	95% H2O/5% D2O	100 mM	7.00	1 atm	308	Bruker AVANCE 600
2	2D 1H-15N HSQC	0.3 mM [99% 13CG]-Thr [99% 13CE]-Met [100% 1HG]-Thr [100% 1HE]-Met [U-100% D] [U-98% 15N] WBSCR27, 5 mM DTT, 0.2 % sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride	100% D2O	100 mM	7.00	1 atm	308	Bruker AVANCE 850
3	3D HNCO	0.8 mM [U-95% 13C; U-99% 15N] WBSCR27, 10 mM DTT, 0.2 % sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride	95% H2O/5% D2O	100 mM	7.00	1 atm	308	Bruker AVANCE 850
4	3D HNCACO	0.8 mM [U-95% 13C; U-99% 15N] WBSCR27, 10 mM DTT, 0.2 % sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride	95% H2O/5% D2O	100 mM	7.00	1 atm	308	Bruker AVANCE 850
5	3D HN(CO)CA	0.8 mM [U-95% 13C; U-99% 15N] WBSCR27, 10 mM DTT, 0.2 % sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride	95% H2O/5% D2O	100 mM	7.00	1 atm	308	Bruker AVANCE 850
8	3D HNCA	0.8 mM [U-95% 13C; U-99% 15N] WBSCR27, 10 mM DTT, 0.2 % sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride	95% H2O/5% D2O	100 mM	7.00	1 atm	308	Bruker AVANCE 850
7	3D CBCA(CO)NH	0.8 mM [U-95% 13C; U-99% 15N] WBSCR27, 10 mM DTT, 0.2 % sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride	95% H2O/5% D2O	100 mM	7.00	1 atm	308	Bruker AVANCE 850
6	3D HNCACB	0.8 mM [U-95% 13C; U-99% 15N] WBSCR27, 10 mM DTT, 0.2 % sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride	95% H2O/5% D2O	100 mM	7.00	1 atm	308	Bruker AVANCE 850
9	3D HBHA(CO)NH	0.8 mM [U-95% 13C; U-99% 15N] WBSCR27, 10 mM DTT, 0.2 % sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride	95% H2O/5% D2O	100 mM	7.00	1 atm	308	Bruker AVANCE 850
10	3D HNHAHB	0.8 mM [U-95% 13C; U-99% 15N] WBSCR27, 10 mM DTT, 0.2 % sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride	95% H2O/5% D2O	100 mM	7.00	1 atm	308	Bruker AVANCE 850
11	3D 1H-15N TOCSY	0.8 mM [U-95% 13C; U-99% 15N] WBSCR27, 10 mM DTT, 0.2 % sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride	95% H2O/5% D2O	100 mM	7.00	1 atm	308	Bruker AVANCE 850
12	3D HCCH-TOCSY	0.3 mM [99% 13CG]-Thr [99% 13CE]-Met [100% 1HG]-Thr [100% 1HE]-Met [U-100% D] [U-98% 15N] WBSCR27, 5 mM DTT, 0.2 % sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride	100% D2O	100 mM	7.00	1 atm	308	Bruker AVANCE 850
13	3D 1H-13C NOESY	0.8 mM [U-95% 13C; U-99% 15N] WBSCR27, 10 mM DTT, 0.2 % sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride	95% H2O/5% D2O	100 mM	7.00	1 atm	308	Bruker AVANCE 850
14	IPAP	0.8 mM [U-15N] WBSCR27, 10 mM DTT, 0.2 % sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride, 0.225 % v/v phage Pf1 stock solution	95% H2O/5% D2O	100 mM	7.00	1 atm	308	Bruker AVANCE 800
17	3D 15N-1H NOESY	0.3 mM [99% 13CG]-Thr [99% 13CE]-Met [100% 1HG]-Thr [100% 1HE]-Met [U-100% D] [U-98% 15N] WBSCR27, 5 mM DTT, 0.2 % sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride	95% H2O/5% D2O	100 mM	7.00	1 atm	308	Bruker AVANCE 800
16	2D DQF-COSY	0.8 mM [U-15N] WBSCR27, 10 mM DTT, 0.2 % w/v sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride	95% H2O/5% D2O	100 mM	7.00	1 atm	308	Bruker AVANCE 600
18	3D 15N-1H NOESY	0.8 mM [U-95% 13C; U-99% 15N] WBSCR27, 10 mM DTT, 0.2 % sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride	95% H2O/5% D2O	100 mM	7.00	1 atm	308	Bruker AVANCE 850

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	600
2	Bruker	AVANCE	850
3	Bruker	AVANCE	800

NMR Refinement
Method	Details	Software
molecular dynamics		CNS

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	200
Conformers Submitted Total Number	20
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	CNS		Brunger A. T. et.al.
5	collection	TopSpin		Bruker Biospin
2	structure calculation	CNS		Brunger, Adams, Clore, Gros, Nilges and Read
3	chemical shift assignment	PINE-SPARKY		Lee W
4	peak picking	NMRFAM-SPARKY		Lee W, Tonelli M, Markley JL

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.